Genpact (G) Cash & Equivalents (2009 - 2026)

Genpact's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $578.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 2.93% year-over-year to $578.1 million; the TTM figure through Mar 2026 stood at $578.1 million (up 2.93% YoY), while the FY2025 annual figure was $853.8 million, up 31.71% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $578.1 million, down from $853.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.0 billion in Q3 2024, with the low at $460.4 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $583.7 million (2023), against an average of $653.9 million.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents tumbled 43.77% in 2022, then surged 89.03% in 2024.
• Genpact's Cash & Equivalents stood at $646.8 million in 2022, then fell by 9.76% to $583.7 million in 2023, then climbed by 11.06% to $648.2 million in 2024, then soared by 31.71% to $853.8 million in 2025, then sank by 32.3% to $578.1 million in 2026.
• Business Quant data shows G's Cash & Equivalents at $578.1 million in Q1 2026, $853.8 million in Q4 2025, and $740.8 million in Q3 2025.